Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.53 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL608555 | 1.00 | SIGMAR1 (0.82) | SIGMAR1SMN1; SMN2LMNAPOLBMAPK1 | |
| N-Benzylamphetamine SCHEMBL2795222 | 0.91 | SIGMAR1 (1.00) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| N-Benzylamphetamine SCHEMBL2451256 | 0.91 | SIGMAR1 (1.00) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| N-Benzylamphetamine SCHEMBL2798189 | 0.91 | SIGMAR1 (1.00) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| N-Benzylamphetamine SCHEMBL8085021 | 0.89 | SIGMAR1 (0.96) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| SCHEMBL606189 | 0.87 | SIGMAR1 (0.85) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| SCHEMBL24997843 | 0.84 | SIGMAR1 (0.79) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| SCHEMBL8091283 | 0.84 | SIGMAR1 (0.79) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| SCHEMBL10005270 | 0.84 | SIGMAR1 (0.79) | SIGMAR1LMNAPOLBMAPK1CYP1A2 | |
| SCHEMBL3235181 | 0.84 | SIGMAR1 (0.79) | SIGMAR1LMNAPOLBMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0591426-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0507863-A4 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | — | 1993-07-07 | — | — | EP | disclosed |
| WO-1993000313-A2 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1993-01-07 | — | — | WO | disclosed |
| EP-0507863-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1992-10-14 | — | — | EP | disclosed |
| WO-1991009594-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1991-07-11 | — | — | WO | disclosed |